The laboratory industry is expanding on two fronts at once. The global IVD market is expected to grow 5.0% and reach $96.2 billion, while 41% of laboratories already use AI-enabled decision support. This set of statistics tracks market growth, adoption, cost pressure, and the measurable impact of automation on turnaround time, error rates, and repeat testing.
Key Takeaways
- 5.0% 2024 expected global growth rate for the in vitro diagnostics (IVD) market
- 3.2% 2023–2028 expected CAGR for the in vitro diagnostics (IVD) market
- $96.2 billion projected global IVD market value in 2029
- 2.6x increase in LIMS deployments in the Asia-Pacific region from 2018 to 2023 (region growth multiple reported by vendor market tracking)
- 41% of laboratories reported implementing AI-enabled decision support for pathology or lab result interpretation (survey adoption)
- 31% of labs reported using automated pre-analytical systems for specimen accessioning and sorting (survey adoption)
- The European Union’s IVD Regulation (EU) 2017/746 entered into application starting 26 May 2022
- The EU CLP (Regulation (EC) No 1272/2008) applies with unified classification and labeling rules since 1 June 2015
- 2010–2023 peer-reviewed evidence shows that digital pathology can improve diagnostic accuracy compared with static images in multiple studies (median improvement reported across included studies)
- 10–20% increase in operational efficiency measured as cost per test reduction after automation adoption (meta range from multiple evaluations)
- 30% reduction in reagent and consumables waste reported after implementing sample auditing and inventory optimization tools (case study results)
- 40% reduction in repeat testing attributed to improved QC and data validation in an implementation report
- A pooled analysis reported 13% reduction in laboratory turnaround time with automation-enabled middleware integration
- Elimination of manual data transcription reduced transcription errors by 60% in a controlled lab workflow study
- 1.7% coefficient of variation (CV) for assay results reported in automation-optimized workflows versus 3.6% CV in manual handling (single-study comparison)
IVD and lab automation are accelerating worldwide, with faster, more accurate diagnostics driven by LIMS, AI, and connected workflows.
Related reading
01 · Category
Market Size3 stats
01
5.0% 2024 expected global growth rate for the in vitro diagnostics (IVD) market
02
3.2% 2023–2028 expected CAGR for the in vitro diagnostics (IVD) market
03
$96.2 billion projected global IVD market value in 2029
Interpretation
Market Size Interpretation
From a market size perspective, the global in vitro diagnostics (IVD) industry is projected to keep expanding steadily with a 5.0% expected 2024 growth rate and a 3.2% CAGR from 2023 to 2028, reaching an estimated $96.2 billion by 2029.
02 · Category
User Adoption8 stats
01
2.6x increase in LIMS deployments in the Asia-Pacific region from 2018 to 2023 (region growth multiple reported by vendor market tracking)
02
41% of laboratories reported implementing AI-enabled decision support for pathology or lab result interpretation (survey adoption)
03
31% of labs reported using automated pre-analytical systems for specimen accessioning and sorting (survey adoption)
04
27% of labs reported using telepathology for remote slide review (survey adoption)
05
4.8 million pathology-related procedures performed in 2022 in US hospitals (procedure volume measure tied to pathology services demand)
06
40% of laboratories reported increasing investment in lab informatics within the past 12 months (survey-reported investment change)
07
18% of clinical laboratory tests are ordered electronically in 2022 (electronic ordering penetration measure from national healthcare IT stats)
08
24% of healthcare facilities reported using cloud-based services for laboratory informatics in 2023 (cloud adoption share from healthcare IT survey)
Interpretation
User Adoption Interpretation
From 2018 to 2023, Asia-Pacific saw a 2.6x increase in LIMS deployments, and when paired with broad survey adoption such as 41% using AI-enabled decision support, 31% deploying automated pre-analytical systems, and 27% adopting telepathology, it suggests user adoption of modern lab informatics and automation is accelerating across multiple lab workflows, not just one.
03 · Category
Industry Trends10 stats
01
The European Union’s IVD Regulation (EU) 2017/746 entered into application starting 26 May 2022
02
The EU CLP (Regulation (EC) No 1272/2008) applies with unified classification and labeling rules since 1 June 2015
03
2010–2023 peer-reviewed evidence shows that digital pathology can improve diagnostic accuracy compared with static images in multiple studies (median improvement reported across included studies)
04
1.1% year-over-year decrease in lab-sector employment in the US during 2023 (BLS employment series for medical and diagnostic laboratories)
05
3.0% increase in US clinical laboratory industry revenue in 2023 (industry performance year-over-year)
06
60% of cyber incidents in healthcare involved credential theft or misuse of existing access (incident pattern share in healthcare dataset)
07
38% of laboratories reported using robotic automation for aliquoting or plating (survey-reported lab automation capability share)
08
29% of laboratory directors cited staffing shortages as the primary driver for adopting automation (survey share of primary driver)
09
2.1% average annual increase in US hospital admissions involving pathology/testing in 2019–2022 (national trend used in healthcare utilization analytics)
10
35% of labs reported participating in federated data-sharing networks for lab results by 2024 (survey share of participation)
Interpretation
Industry Trends Interpretation
Under current industry trends, labs are adapting on multiple fronts as the EU IVD Regulation took effect on 26 May 2022, US lab-sector employment fell 1.1% in 2023 even as clinical lab revenue rose 3.0%, and cybersecurity risks remain severe with 60% of healthcare cyber incidents tied to credential theft or misuse of access.
More related reading
04 · Category
Cost Analysis7 stats
01
10–20% increase in operational efficiency measured as cost per test reduction after automation adoption (meta range from multiple evaluations)
02
30% reduction in reagent and consumables waste reported after implementing sample auditing and inventory optimization tools (case study results)
03
40% reduction in repeat testing attributed to improved QC and data validation in an implementation report
04
$10.1 billion global laboratory automation systems market size in 2020
05
$2.5 billion projected global LIMS market revenue by 2030 (forecast value)
06
2.0% average annual increase in lab procurement costs in the US during 2022 (BLS Producer Price Index for medical laboratory supplies/services component cited in PPI series notes)
07
$3.3 million average annual savings for mid-sized laboratories after adopting shared services for IT and lab informatics (survey-reported mean savings)
Interpretation
Cost Analysis Interpretation
From the cost analysis perspective, labs are seeing measurable savings and efficiency gains such as a 30% drop in reagent and consumables waste and a 40% reduction in repeat testing, while the continued growth of automation and LIMS markets to $10.1 billion in 2020 and a $2.5 billion projected LIMS revenue by 2030 suggests these investments are increasingly being driven by the need to offset rising procurement costs that increased by 2.0% annually in the US during 2022.
05 · Category
Performance Metrics7 stats
01
A pooled analysis reported 13% reduction in laboratory turnaround time with automation-enabled middleware integration
02
Elimination of manual data transcription reduced transcription errors by 60% in a controlled lab workflow study
03
1.7% coefficient of variation (CV) for assay results reported in automation-optimized workflows versus 3.6% CV in manual handling (single-study comparison)
04
99.9% uptime target specified for laboratory-grade uninterrupted power supply (UPS) systems used in analytical labs (typical design requirement referenced by IEC standards guidance)
05
2.5-hour median sample-to-result time reported for STAT workflows using digital connectivity between ordering and lab systems (reported median in operations evaluation)
06
0.8% invalid result rate after implementing LIMS data validation rules (reported baseline-to-after improvement)
07
0.01% sample identification mismatch rate target for LIS/LIMS-enabled specimen handling (reported error-rate target in accreditation guidance)
Interpretation
Performance Metrics Interpretation
Performance metrics show that automation and connected lab workflows materially improve efficiency and quality, cutting turnaround time by 13% and sample-to-result time to a 2.5-hour median for STAT cases while also reducing transcription errors by 60% and bringing assay variability down to 1.7% CV from 3.6% under manual handling.
06 · Category
Workforce2 stats
01
2.4 million medical lab and diagnostic workers in the US (employment count, reflecting laboratory workforce scale)
02
1,000+ accredited medical laboratories in the US that maintain CLIA registration (CLIA-certified laboratory counts)
Interpretation
Workforce Interpretation
With 2.4 million medical lab and diagnostic workers in the US supported by 1,000 plus CLIA registered accredited laboratories, the workforce behind laboratory care is large and widely distributed across accredited facilities.
report visual · Breakdown
Digital & Automation Adoption in Clinical Labs
Key shares of labs adopting AI decision support, automated pre-analytics, telepathology, and robotic automation highlight accelerating digitization.
40%
40% of laboratories reported increasing investment in lab informatics within the past 12 months (survey-reported investm
60%
60% of cyber incidents in healthcare involved credential theft or misuse of existing access (incident pattern share in h
source-verifiedaamc.org · verizon.com
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Karl Becker. (2026, February 13). Laboratory Industry Statistics. Gitnux. https://gitnux.org/laboratory-industry-statistics
MLA
Karl Becker. "Laboratory Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/laboratory-industry-statistics.
Chicago
Karl Becker. 2026. "Laboratory Industry Statistics." Gitnux. https://gitnux.org/laboratory-industry-statistics.
Sources & references
37 datasets cited across this report · attribution is report-level
+14 additional datasets cited (not shown individually)